Literature DB >> 23216017

The influence of metastatic site on the expression of CEA and cellular localization of β-catenin in colorectal cancer.

U Subrahmanyeswara Rao1, Nicole S Hoerster, Seshadri Thirumala, Prema S Rao.   

Abstract

BACKGROUND AND AIM: The usefulness of carcinoembryonic antigen (CEA) in the diagnosis and prognosis of colorectal cancer (CRC) is unclear. The aim was to analyze changes in the expression of CEA during CRC progression and metastasis, so as to determine the influence of tumor metastatic organ on the CEA expression by CRC cells.
METHODS: The human biopsies of adenocarcinomas in colon and CRC liver and lung metastases were analyzed by immunohistochemistry for the expression of CEA. Expression of E-cadherin and β-catenin was also analyzed to localize the CRC neoplastic glands in metastatic tissues.
RESULTS: The CRC neoplastic glands in colon and liver expressed significantly higher amount of CEA compared with crypts in normal colon. In contrast, CRC neoplastic glands formed in lung expressed low CEA level. However, CEA expression was high in areas of tumor necrosis in lung. E-cadherin and β-catenin were cell membrane-bound in normal crypts and CRC neoplastic glands in colon and liver. Although these two proteins were also cell membrane-bound in a majority of CRC neoplastic glands in lungs, a significant proportion of these expressed β-catenin in the nucleus, which lacked either E-cadherin or β-catenin at the cell membrane.
CONCLUSION: Our findings indicate that lung microenvironment is unique in that it suppresses the expression of CEA by CRC cells forming neoplastic glands. In addition, lung microenvironment promotes nuclear localization of β-catenin, suggesting that the Wnt signaling pathway is relatively active highly in CRC metastasized to lung, when compared with liver or colon.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23216017     DOI: 10.1111/jgh.12083

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Carcinoembryonic antigen reduction after medical treatment in patients with metastatic colorectal cancer: a systematic review and meta-analysis.

Authors:  Giuseppe Antonio Colloca; Antonella Venturino; Domenico Guarneri
Journal:  Int J Colorectal Dis       Date:  2019-01-22       Impact factor: 2.571

2.  Feasibility of mesorectal vascular invasion in predicting early distant metastasis in patients with stage T3 rectal cancer based on rectal MRI.

Authors:  Young Chul Kim; Jai Keun Kim; Myeong-Jin Kim; Jei Hee Lee; Young Bae Kim; Sung Jae Shin
Journal:  Eur Radiol       Date:  2015-05-28       Impact factor: 5.315

3.  Heterogeneity in the expression of receptors in the human breast cancer metastasized to the brain.

Authors:  Prema S Rao; Morgan Labhart; Susan L Mayhew; Seshadri Thirumala; U Subrahmanyeswara Rao
Journal:  Tumour Biol       Date:  2014-04-29

Review 4.  Management of resectable colorectal lung metastases.

Authors:  Sing Yu Moorcraft; George Ladas; Anne Bowcock; Ian Chau
Journal:  Clin Exp Metastasis       Date:  2015-12-10       Impact factor: 5.150

5.  Factors predicting long-term survival in colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.

Authors:  Jung Wook Huh; Chang Hyun Kim; Sang Woo Lim; Hyeong Rok Kim; Young Jin Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-06-14       Impact factor: 4.553

6.  High-Precision Quantitative Analysis Reveals Carcinoembryonic Protein Expression Differs Among Colorectal Cancer Primary Foci and Metastases to Different Sites.

Authors:  Yazhen Zhu; Qin Zhang; Chengjiang Wei; Ying Hu; Han Gong; Yi Liu; Hao Lai; Yan Feng; Yuan Lin
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.